ARCHIVES

Agency Expands Gleevec Label To Include Rare GIST Subset

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma

August 30, 2013

Alvarez Named New President of The Society of Gynecologic Oncology; Society Restructures

April 13, 2012

Rosenberg’s Gene Transfer Protocol Approved By NIH Advisory Group

October 7, 1988

Overwhelming 89 To 7 Vote By Senate Overturns President Reagan’s Veto Of NIH Reauthorization

November 29, 1985

NCI-Approved Clinical Trials

August 31, 2001